2
J. Johny et al. / Biotechnology Reports 24 (2019) e00375
of the target compound we have designed reactions where enzyme
catalyzed transformations can be employed. The unique character-
istics of enzymes like milder reaction conditions, better selectivity
have made them as routine catalysts in organic synthesis. These
characteristics of the biocatalyst provide organic chemists an
opportunity to avoid or at least reduce the usage of toxic reagents
which are used in a multi step organic synthesis [9,10]. Also there
has been an increased interest in enzymatic transformations
conducted in non-conventional organic medium such as organic
solvents as solubility of many organic compounds is facilitated in
solvents rather than water [11]. Hence, the aim of the work was to
synthesize the target compound employing a bioorganic route and
evaluate its preliminary activities.
potassium hydroxide solution (150 mL) were stirred at 100 ꢀC for
16 h. The progress of the reaction was monitored by TLC using
hexane and ethyl acetate (70:30; v/v). After complete conversion,
the temperature was brought to about 25 ꢀC and the pH was
adjusted to 1 by adding concentrated hydrochloric acid. The
resulting precipitate was filtered and dried under reduced pressure
to obtain 11-hydroxyundecanoic acid as a white solid in 1.45 g
(95%).
mp: 65–66 ꢀC.
1H NMR (300 MHz, CDCl3)
d 1.28 (m, (CH2)6, 12 H), 1.62 (m,
(CH2)2, 4 H), 2.34 (t, J = 7.6 Hz, CH2, 2H,), 3.63 (t, J = 6.8 Hz, CH2,
2 H).
IR (cmÀ1): 1216.38 cmÀ1, 3022.17 cmÀ1, 3400.55 cmÀ1
.
MS: M-1 = 201.33
2. Materials and methods
2.2.3. Preparation of (E)-11-(3-(4-hydroxy-3-methoxyphenyl)
acryloyloxy) undecanoic acid (5)
2.1. General information
Vinyl ferulate (900 mg; 4.09 mmol) and 11-hydroxyundecanoic
acid (1.03 g; 5.11 mmol; 1.25 eq) were solubilized in 10 mL of
hexane and 2-butanone (2:1; v/v) and to this mixture was added
immobilized lipase from Candida antarctica (15% to wt of
substrates). The reaction mixture was stirred at 60 ꢀC while
monitoring the progress by TLC using hexane and ethyl acetate
(80:20; v/v). Product formation was observed from the third day
onwards and another 5% of lipase was added to the reaction
mixture. After maximum conversion, the reaction mixture was
diluted with ethyl acetate and the lipase was washed several times
with the solvent and separated by filtration. Solvent was
evaporated and the crude product was purified by column
chromatography (hexane and ethyl acetate (90:10; v/v) to obtain
the ferulic acid ester of hydroxy undecanoic acid in 570 mg (37%).
Solketal (DL – 1,2 – Isopropylidineglycerol), ferulic acid, vinyl
acetate and 11-bromoundecanoic acid were purchased from
Sigma. Potassium hydroxide, mercuric acetate, sulphuric acid,
hydrochloric acid, silica gel for column chromatography were
purchased from SRL chemicals, merck, Avera, Advent and Acme
Synthetic Chemicals, Mumbai, India respectively. All solvents were
procured from Merck and were of highest grade of purity.
Immobilized lipase from Candida antarctica (CAL-B) was procured
from Novozymes Bagsvaerd, Denmark).
The proton NMR spectra were recorded on Varian 500/300 and
125/75 MHz instrument and TMS was used as an internal standard.
Mass spectra were recorded using electron spray ionization on
Waters e2695 Seperators module (Waters, Milford, MA, USA) mass
spectrometer. Infra red (IR) spectra were recorded using a Perkin-
Elmer Fourier transform (FT)-IR Spectrum BX instrument (Model:
Spectrum BX; Connecticut, USA). All the synthesized compounds
were purified by silica gel (60–120 mesh) column chromatography
(Acme Synthetic Chemicals, Mumbai, India) and were identified by
thin-layer chromatography (TLC). TLC was performed on precoated
silica gel 60 F254 from Merck (Darmstadt, Germany).
1H NMR (300 MHz, CDCl3):
d 1.29 (s, (CH2)6, 12 H), 1.63–1.71 (m,
(CH2)2, 4 H), 2.35 (t, J = 7.5 Hz, CH2, 2H), 3.65 (t, ÀOCH2, J = 6.6 Hz,
2 H), 3.94 (s, ÀOCH3, 3 H), 6.26 (d, J = 15.9 Hz, = CH, 1 H), 6.93 (d,
J = 8.1, 5.5 Hz, ArH, 1 H), 7.13–7.02 (m, ArH, 2 H), 7.58 (d,
J = 15.9 Hz, = CH, 1 H); IR (cmÀ1): 1742.56 cmÀ1, 2938.90 cmÀ1
,
2985.89 cmÀ1, 3460.28 cmÀ1
MS: M-1 = 377.34.
2.2. Synthesis
2.2.4. Synthesis of (E)-(2, 2-dimethyl-1,3-dioxolan-4-yl)methyl 11-(3-
(4-hydroxy-3-methoxyphenyl)acryloyloxy)undecanoate (7)
2.2.1. Preparation of vinyl ferulate (2)
Ferulic acid ester of 11-hydroxyundecanoic acid (570 mg;
1.5 mmol) and solketal (250 mg; 1.96 mmol; 1.3 eq) were
solubilised in a mixture of 10 mL of hexane: 2-butanone (2:1; v/
v). To this mixture, immobilized lipase from Candida antarctica
(10% to wt of substrates) was added and the reaction mixture was
magnetically stirred at 60 ꢀC. After maximum conversion, the
reaction mixture was filtered to separate the lipase, extracted with
ethyl acetate, washed with water and dried over anhydrous sodium
sulphate to obtain the crude product. The crude product was
purified by column chromatography (hexane and ethyl acetate
(92:8; v/v) to obtain pure acetonide in 250 mg (34% yield).
Vinyl ferulate was synthesized from ferulic acid and vinyl
acetate following a reported protocol with slight modifications
[12]. To a mixture of ferulic acid (1.5 g, 7.73 mmol) and vinyl acetate
(11.4 mL, 123.68 mmol) in tetrahydrofuran (20 mL), mercury
acetate (4%, w/w) was added and the mixture was stirred for
30 min under nitrogen atmosphere. After 30 min, 2–4 mL of
sulphuric acid was added and the mixture was stirred overnight
at 40 ꢀC. After 12 h, excess of sodium acetate (20 mg) was added
followed by the removal of vinyl acetate and solvent. The
remaining crude reaction product was purified by column
chromatography (hexane and ethyl acetate (92:8 v/v) to obtain
pure vinyl ferulate in 1.2 g (70.6%) at Rf 0.87 on TLC run on hexane:
ethyl acetate (80:20; v/v).
1H NMR (300 MHz, CDCl3):
d 1.29 (s, (CH2)9, 18 H), 1.67–1.71 (m,
(CH2)2, 4 H), 2.30 (t, J = 7.5 Hz, CH2, 2 H), 3.62–3.66 (m, CH2, ÀOCH2,
4 H), 3.93 (s, ÀOCH3, 3 H), 4.05 (t, J = 6.7 Hz, CH, 1 H), 4.19 (t, J = 6.7
H, CH2, 2 H), 5.85 (s, OH, 1 H), 6.29 (d, J = 15.9 Hz, ( = CH), 1 H), 6.89
(d, ArH, 1 H), 7.01–7.08 (m, ArH, 2 H), 7.61 (d, J = 15.9 Hz, ( = CH),
1H NMR (300 MHz, CDCl3)
d 3.93 (s, CH3, 3 H), 4.62 (dd, 7.78 Hz,
1.52 Hz, = CH, 1 H), 4.94 (dd, 15.56 Hz, 1.67 Hz, = CH, 1 H), 5.94 (s,
OH, 1 H), 6.28(d, 15.86, = CH, 1 H), 6.92 (d, 8.08 Hz, = CH, 1 H), 7.04
(d, ArH, 1 H), 7.08–7.11 (m, ArH, 2 H), 7.43–7.45 (m, = CH, 1 H), 7.70
1 H); IR (cmÀ1): 1216.08 cmÀ1 1708.62 cmÀ1 2858.29 cmÀ1
, , ,
2928.19, 3021.31 cmÀ1, 3389.21 cmÀ1; MS: = M + 23 = 515.28
(d, 15.86, = CH, 1 H); IR (cmÀ1): 1718.58 cmÀ1, 3021.04 cmÀ1
,
3417.78 cmÀ1; MS: M-1 = 219.22.
2.2.5. Synthesis of 1- [11-(ferulyloxy) undecanoyl)] glycerol (8)
A mixture of acetonide (7) of previous step (130 mg, 0.003 mol)
dissolved in methanol (10 mL) was placed in ice bath and to this
cooled solution was added 2 M aqueous hydrochloric acid (0.5 mL,
1.5 eq) in one portion. After few minutes, the ice bath was removed
and the reaction mixture was stirred for about 4 h at room
2.2.2. Preparation of 11-hydroxyundecanoic acid (4)
11-hydroxyundecanoic acid prepared from 11-bromoundeca-
noic acid employing a reported protocol [13]. Briefly, a mixture of
11-bromoundecanoic acid (2 g, 7.54 mmol) and a solution of 2 M aq